Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

BACKGROUND: The Trastuzumab for Gastric Cancer (ToGA) study is the first international trial to include Japanese patients with human epidermal growth factor 2 (HER2) positive advanced/metastatic gastric or gastroesophageal junction cancer. ToGA showed that trastuzumab plus chemotherapy (capecitabine...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawaki, Akira, Ohashi, Yasuo, Omuro, Yasushi, Satoh, Taroh, Hamamoto, Yasuo, Boku, Narikazu, Miyata, Yoshinori, Takiuchi, Hiroya, Yamaguchi, Kensei, Sasaki, Yasutsuna, Nishina, Tomohiro, Satoh, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Hatake, Kiyohiko, Ohtsu, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390686/
https://www.ncbi.nlm.nih.gov/pubmed/22179434
http://dx.doi.org/10.1007/s10120-011-0118-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390686/
https://www.ncbi.nlm.nih.gov/pubmed/22179434
http://dx.doi.org/10.1007/s10120-011-0118-1

Ejemplares similares